These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 3780125)

  • 1. Quantitation of drug levels and platelet receptor blockade caused by a thromboxane antagonist.
    Friedhoff LT; Manning J; Funke PT; Ivashkiv E; Tu J; Cooper W; Willard DA
    Clin Pharmacol Ther; 1986 Dec; 40(6):634-42. PubMed ID: 3780125
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antithrombotic effects of the thromboxane A2 antagonist, SQ 28,668, in vitro and in the coronary circulation in vivo.
    Ogletree ML; Harris DN; Heran CL; Phillips MB; Michel IM; Goldenberg HJ
    Eicosanoids; 1988; 1(2):85-91. PubMed ID: 2856188
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetic and pharmacodynamic properties of FK070 (KDI-792), a novel thromboxane receptor antagonist/thromboxane synthetase inhibitor, after single and multiple oral administrations to healthy volunteers.
    Uematsu T; Kosuge K; Umemura K; Nakano M; Terakawa M; Nakashima M
    J Pharm Pharmacol; 1996 Apr; 48(4):380-5. PubMed ID: 8794987
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protamine-induced pulmonary hypertension in heparinized monkeys and pigs is inhibited by the thromboxane receptor antagonist SQ 30,741.
    Schumacher WA; Heran CL; Ogletree ML
    Eicosanoids; 1990; 3(2):87-93. PubMed ID: 2144979
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Myocardial salvage efficacy of a thromboxane receptor antagonist, SQ, 30,741, in relation to inhibition ex vivo of platelet function in the ferret.
    Gomoll AW; Ogletree ML
    Prostaglandins; 1993 Sep; 46(3):233-42. PubMed ID: 8234831
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Desensitisation of human platelets against stimulation by thromboxane mimics--reduction in receptor capacity and loss of functional response.
    Thierauch KH; Gabriel D; Prior G; Schillinger E
    Biomed Biochim Acta; 1988; 47(10-11):S75-8. PubMed ID: 2470362
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Heterogeneity of prostaglandin H2/thromboxane A2 receptors: distinct subtypes mediate vascular smooth muscle contraction and platelet aggregation.
    Furci L; Fitzgerald DJ; Fitzgerald GA
    J Pharmacol Exp Ther; 1991 Jul; 258(1):74-81. PubMed ID: 1830100
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preliminary assessment of a novel thromboxane A2 receptor-blocking drug, GR32191, in healthy subjects.
    Thomas M; Lumley P
    Circulation; 1990 Jan; 81(1 Suppl):I53-8; discussion I59-60. PubMed ID: 2136818
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of the thromboxane A2/prostaglandin endoperoxide receptor antagonist SQ 30,741 on myocardial infarct size and blood flow during myocardial ischemia and reperfusion.
    Grover GJ; Schumacher WA; Simon M; Parham C
    J Cardiovasc Pharmacol; 1988 Dec; 12(6):701-9. PubMed ID: 2467089
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combined administration of 5-HT2 and thromboxane A2 antagonists: effects on platelet aggregation and isolated cardiac muscle.
    Shaw LA; Batey AJ; Coker SJ
    Br J Pharmacol; 1997 Jul; 121(5):875-82. PubMed ID: 9222543
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetic and pharmacodynamic profiles of vapiprost, a selective, long-lasting thromboxane receptor antagonist, after single and multiple oral administration to healthy volunteers.
    Uematsu T; Nagashima S; Mizuno A; Hirano K; Nakashima M
    J Clin Pharmacol; 1991 Sep; 31(9):815-22. PubMed ID: 1839540
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of SQ 30741 on thromboxane receptor-mediated responses in the feline pulmonary vascular bed.
    McMahon TJ; Hood JS; Nossaman BD; Ibrahim IN; Feng CJ; Kadowitz PJ
    J Appl Physiol (1985); 1991 Nov; 71(5):2012-8. PubMed ID: 1837015
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interspecies differences in thromboxane receptors: studies with thromboxane receptor antagonists in rat and guinea pig smooth muscles.
    Ogletree ML; Allen GT
    J Pharmacol Exp Ther; 1992 Feb; 260(2):789-94. PubMed ID: 1531361
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Magnitude of thromboxane receptor antagonism necessary for antithrombotic activity in monkeys.
    Schumacher WA; Heran CL; Goldenberg HJ; Harris DN; Ogletree ML
    Am J Physiol; 1989 Mar; 256(3 Pt 2):H726-34. PubMed ID: 2522282
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antiplatelet effects of the novel thromboxane A2 receptor antagonist sodium (E)-11-[2-(5,6-dimethyl-1-benzimidazolyl)-ethylidene]-6,11- dihydrodibenz[b,e] oxepine-2-carboxylate monohydrate.
    Karasawa A; Kawakage M; Shirakura S; Higo K; Kubo K; Ohshima E; Obase H
    Arzneimittelforschung; 1991 Dec; 41(12):1230-6. PubMed ID: 1840011
    [TBL] [Abstract][Full Text] [Related]  

  • 16. On the mechanism of the prolonged action in man of GR32191, a thromboxane receptor antagonist.
    Ritter JM; Doktor HS; Benjamin N; Barrow SE; Stewart-Long P
    Adv Prostaglandin Thromboxane Leukot Res; 1991; 21A():351-4. PubMed ID: 1825568
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phenol red is a thromboxane A2/prostaglandin H2 receptor antagonist in canine lingual arteries and human platelets.
    Greenberg SS; Johns A; Kleha J; Xie J; Wang Y; Bianchi J; Conley K
    J Pharmacol Exp Ther; 1994 Mar; 268(3):1352-61. PubMed ID: 8138950
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Direct myocardial effects of the thromboxane A2/prostaglandin H2 agonists U-46619 and SQ 26,655 under ischemic and nonischemic conditions.
    Grover GJ; Hedberg A; Ogletree ML
    Pharmacology; 1990; 41(1):1-15. PubMed ID: 2122481
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Binding of a thromboxane A2/prostaglandin H2 receptor antagonist to washed human platelets.
    Mais DE; Burch RM; Saussy DL; Kochel PJ; Halushka PV
    J Pharmacol Exp Ther; 1985 Dec; 235(3):729-34. PubMed ID: 3001275
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacological characterization of potent, long-acting thromboxane receptor antagonists, SQ 33,261 and SQ 33,552.
    Harris DN; Michel IM; Goldenberg HJ; Hartl KS; Allen GT; Steinbacher TE; Schumacher WA; Han WC; Hall SE; Floyd DM
    J Pharmacol Exp Ther; 1992 Apr; 261(1):131-7. PubMed ID: 1532833
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.